Strategies for Design of Non Peptide CCK1R Agonist/Antagonist Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 12, 2007-06 ,pp. : 1180-1194

Bentham Science Publishers

Access to resources Recommend Favorite

How a single inversion of configuration leads to a reversal of the binding mode: proposal of a novel arrangement of CCK 2 ligands in their receptor, and contribution to the development of peptidomimetic or non-peptide CCK 2 ligands

By Bellier B.   Garbay C.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 671-686

Elsevier

Access to resources Recommend Favorite

Characterisation of the effects of SR146131, a novel non-peptide CCK 1 receptor agonist, on IMR-32 human neuroblastoma cells

By Schaeffer P.   Nestor A.L.   Prabonnaud V.   Bachy A.   Laplace M.C.   Keane P.E.   Bignon E.   Herbert J.M.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 303-310

Elsevier

Access to resources Recommend Favorite

Structure-based design in drug discovery - the application of a peptoid drug design strategy for the development of non-peptide neuropeptide receptor ligands

By Pritchard M.C.   Raphy J.   Singh L.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite

Effect of FK3657, a non-peptide bradykinin B 2 receptor antagonist, on allergic airway disease models

By Hirayama Y.   Miyayasu K.   Yamagami K.   Imai T.   Ohkubo Y.   Mutoh S.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite